ALNY logo

Alnylam Pharmaceuticals (ALNY) Interest expense

annual interest expense:

$141.86M+$20.64M(+17.02%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ALNY annual interest expense is $141.86 million, with the most recent change of +$20.64 million (+17.02%) on December 31, 2024.
  • During the last 3 years, ALNY annual interest expense has fallen by -$1.16 million (-0.81%).
  • ALNY annual interest expense is now -9.05% below its all-time high of $155.97 million, reached on December 31, 2022.

Performance

ALNY Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

quarterly interest expense:

$38.65M-$325.00K(-0.83%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY quarterly interest expense is $38.65 million, with the most recent change of -$325.00 thousand (-0.83%) on March 31, 2025.
  • Over the past year, ALNY quarterly interest expense has increased by +$3.39 million (+9.62%).
  • ALNY quarterly interest expense is now -9.30% below its all-time high of $42.61 million, reached on June 30, 2022.

Performance

ALNY quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

TTM interest expense:

$145.25M+$3.39M(+2.39%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY TTM interest expense is $145.25 million, with the most recent change of +$3.39 million (+2.39%) on March 31, 2025.
  • Over the past year, ALNY TTM interest expense has increased by +$17.73 million (+13.91%).
  • ALNY TTM interest expense is now -10.82% below its all-time high of $162.87 million, reached on September 30, 2022.

Performance

ALNY TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

ALNY Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.0%+9.6%+13.9%
3 y3 years-0.8%-8.8%-5.0%
5 y5 years+100.0%+100.0%+100.0%

ALNY Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.1%+17.0%-9.3%+33.5%-10.8%+21.3%
5 y5-year-9.1%>+9999.0%-9.3%>+9999.0%-10.8%>+9999.0%
alltimeall time-9.1%>+9999.0%-9.3%>+9999.0%-10.8%>+9999.0%

ALNY Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$38.65M(-0.8%)
$145.25M(+2.4%)
Dec 2024
$141.86M(+17.0%)
$38.97M(+13.4%)
$141.86M(+5.7%)
Sep 2024
-
$34.38M(+3.4%)
$134.22M(+2.7%)
Jun 2024
-
$33.26M(-5.7%)
$130.74M(+2.5%)
Mar 2024
-
$35.25M(+12.5%)
$127.52M(+5.2%)
Dec 2023
$121.22M(-22.3%)
$31.34M(+1.4%)
$121.22M(+1.2%)
Sep 2023
-
$30.89M(+2.9%)
$119.80M(-7.8%)
Jun 2023
-
$30.04M(+3.7%)
$129.99M(-8.8%)
Mar 2023
-
$28.95M(-3.2%)
$142.56M(-8.6%)
Dec 2022
$155.97M(+9.1%)
$29.91M(-27.2%)
$155.97M(-4.2%)
Sep 2022
-
$41.08M(-3.6%)
$162.87M(+0.5%)
Jun 2022
-
$42.61M(+0.6%)
$162.06M(+6.0%)
Mar 2022
-
$42.36M(+15.1%)
$152.87M(+6.9%)
Dec 2021
$143.02M
$36.82M(-8.6%)
$143.02M(+6.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
$40.27M(+20.5%)
$134.72M(+9.4%)
Jun 2021
-
$33.42M(+2.8%)
$123.18M(+5.3%)
Mar 2021
-
$32.52M(+14.0%)
$117.01M(+38.5%)
Dec 2020
$84.50M(>+9900.0%)
$28.52M(-0.7%)
$84.50M(+50.9%)
Sep 2020
-
$28.73M(+5.4%)
$55.98M(+105.4%)
Jun 2020
-
$27.25M(>+9900.0%)
$27.25M(>+9900.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00
$0.00
Dec 2018
$0.00(0.0%)
-
-
Dec 2009
$0.00(-100.0%)
-
-
Dec 2008
$872.00K(-19.5%)
-
-
Dec 2007
$1.08M
-
-

FAQ

  • What is Alnylam Pharmaceuticals annual interest expense?
  • What is the all time high annual interest expense for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual interest expense year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly interest expense?
  • What is the all time high quarterly interest expense for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly interest expense year-on-year change?
  • What is Alnylam Pharmaceuticals TTM interest expense?
  • What is the all time high TTM interest expense for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals TTM interest expense year-on-year change?

What is Alnylam Pharmaceuticals annual interest expense?

The current annual interest expense of ALNY is $141.86M

What is the all time high annual interest expense for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual interest expense is $155.97M

What is Alnylam Pharmaceuticals annual interest expense year-on-year change?

Over the past year, ALNY annual interest expense has changed by +$20.64M (+17.02%)

What is Alnylam Pharmaceuticals quarterly interest expense?

The current quarterly interest expense of ALNY is $38.65M

What is the all time high quarterly interest expense for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly interest expense is $42.61M

What is Alnylam Pharmaceuticals quarterly interest expense year-on-year change?

Over the past year, ALNY quarterly interest expense has changed by +$3.39M (+9.62%)

What is Alnylam Pharmaceuticals TTM interest expense?

The current TTM interest expense of ALNY is $145.25M

What is the all time high TTM interest expense for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high TTM interest expense is $162.87M

What is Alnylam Pharmaceuticals TTM interest expense year-on-year change?

Over the past year, ALNY TTM interest expense has changed by +$17.73M (+13.91%)
On this page